Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches
Journal Title
Expert Review of Anti-Infective Therapy
Publication Type
Review
Abstract
INTRODUCTION: Penicillin allergy is common, and there is increased clinician interest in direct oral challenge (DOC) as a testing strategy for low-risk penicillin allergy. To aid wider implementation of DOC, consensus definitions of low-risk penicillin allergy phenotypes, and standardized approaches to assessment, DOC procedures, and evaluation, are required. AREAS COVERED: This review systematically reviews studies that have utilized penicillin DOC in healthcare settings to identify heterogeneity in implementation approaches and synthesize low-risk definitions, procedures, and evaluation. EXPERT OPINION: Opportunity exists to standardize penicillin DOC procedures in patients with a low-risk penicillin allergy to optimize antimicrobial prescribing and reduce the burden of penicillin allergy. Standardizing the definitions of 'low-risk' and 'positive challenge,' and improving the evaluation of patient safety, alongside the development of a unified approach to the structure of undertaking an oral challenge, is likely to increase uptake and confidence among non-allergist clinicians.
Publisher
Taylor & Francis
Keywords
Humans; Anti-Bacterial Agents/adverse effects; Skin Tests/methods; Penicillins/adverse effects; *Drug Hypersensitivity/diagnosis/prevention & control; *Hypersensitivity; Allergy; antibiotic; antimicrobial stewardship; delabeling; oral challenge; penicillin
Department(s)
Infectious Diseases
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-03-13 05:27:10
Last Modified: 2024-03-13 05:27:28

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙